Lv3
370 积分 2023-07-27 加入
The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
1天前
已完结
Soluble guanylate cyclase agonist, isoliquiritigenin attenuates renal damage and aortic calcification in a rat model of chronic kidney failure
1天前
已完结
A novel soluble guanylate cyclase activator, avenciguat, in combination with empagliflozin, protects against renal and hepatic injury in diabetic db/db mice
1天前
待确认
Activating soluble guanylyl cyclase attenuates ischemic kidney damage
1天前
已完结
Coexistence of Fabry Disease and Membranous Nephropathy: A Case Report
5天前
已关闭
Renal effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
15天前
已完结
Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?
15天前
已完结
Effectiveness of Vericiguat on right ventricle to pulmonary artery uncoupling associated with heart failure with reduced ejection fraction
15天前
已完结
The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis
15天前
已完结
A CoQ10 Analog Ameliorates Cognitive Impairment and Early Brain Injury after Subarachnoid Hemorrhage by Regulating Ferroptosis and Neuroinflammation
22天前
已完结
皖公网安备34019202002308
